Publications in collaboration with researchers from Hospital General Universitario de Alicante (10)

2026

  1. Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort

    Clinical Microbiology and Infection

  2. PROA-COMPLEX: redefiniendo los programas de optimización del uso de antimicrobianos para mejorar los resultados clínicos en pacientes de alto riesgo con infecciones graves

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 39, Núm. 3, pp. 191-237

2025

  1. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 43, Núm. 9, pp. 611-615

2024

  1. How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations

    Enfermedades infecciosas y microbiologia clinica (English ed.), Vol. 42, Núm. 8, pp. 442-452

2022

  1. Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 7, pp. 1996-2002

2021

  1. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

    Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520

  2. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

  3. Real-world experience with bezlotoxumab for prevention of recurrence of clostridioides difficile infection

    Journal of Clinical Medicine, Vol. 10, Núm. 1, pp. 1-9

2020

  1. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort

    American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462

2019

  1. Perspective of Spanish medical students regarding undergraduate education in infectious diseases, bacterial resistance and antibiotic use

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 1, pp. 25-30